1. Happy Thanksgiving from Cafepharma! Our news staff will be off on Thursday, and will be feeding news on a limited basis throughout the holiday weekend. CP Today will return on Monday, November 30. We hope you enjoy this time, and stay safe! — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

New products drive sales at Abbott in Q1

Discussion in 'Abbott' started by anonymous, Apr 18, 2018 at 9:16 AM.

  1. anonymous

    anonymous Guest

    Abbott reported worldwide sales of $7.4 billion for the first quarter of 2018, an increase of 16.7% versus the prior-year period, helped by new product launches.
    Net earnings on a GAAP basis came in at $418 million or $0.23 per share, down slightly from the prior-year quarter. On an adjusted basis, EPS was $0.59.
    Worldwide sales in the Nutrition segment increased 7% while sales in the Diagnostics segment grew 58.7% during Q1 2018. Established Pharmaceuticals sales rose 9.9%, while Medical Devices sales improved 14.6% compared to last year. https://news.alphastreet.com/update-1-new-products-drive-sales-at-abbott-in-q1/